1. Home
  2. BFAM vs MDGL Comparison

BFAM vs MDGL Comparison

Compare BFAM & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BFAM
  • MDGL
  • Stock Information
  • Founded
  • BFAM 1986
  • MDGL 2011
  • Country
  • BFAM United States
  • MDGL United States
  • Employees
  • BFAM N/A
  • MDGL N/A
  • Industry
  • BFAM Other Consumer Services
  • MDGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • BFAM Consumer Discretionary
  • MDGL Health Care
  • Exchange
  • BFAM Nasdaq
  • MDGL Nasdaq
  • Market Cap
  • BFAM 7.2B
  • MDGL 6.1B
  • IPO Year
  • BFAM 1997
  • MDGL N/A
  • Fundamental
  • Price
  • BFAM $99.53
  • MDGL $437.23
  • Analyst Decision
  • BFAM Buy
  • MDGL Strong Buy
  • Analyst Count
  • BFAM 7
  • MDGL 10
  • Target Price
  • BFAM $135.14
  • MDGL $485.78
  • AVG Volume (30 Days)
  • BFAM 673.0K
  • MDGL 292.1K
  • Earning Date
  • BFAM 11-03-2025
  • MDGL 10-30-2025
  • Dividend Yield
  • BFAM N/A
  • MDGL N/A
  • EPS Growth
  • BFAM 75.19
  • MDGL N/A
  • EPS
  • BFAM 3.05
  • MDGL N/A
  • Revenue
  • BFAM $2,790,342,000.00
  • MDGL $515,547,000.00
  • Revenue This Year
  • BFAM $10.42
  • MDGL $394.08
  • Revenue Next Year
  • BFAM $7.11
  • MDGL $61.80
  • P/E Ratio
  • BFAM $32.59
  • MDGL N/A
  • Revenue Growth
  • BFAM 9.24
  • MDGL 3421.98
  • 52 Week Low
  • BFAM $99.40
  • MDGL $200.63
  • 52 Week High
  • BFAM $139.25
  • MDGL $463.63
  • Technical
  • Relative Strength Index (RSI)
  • BFAM 21.92
  • MDGL 56.61
  • Support Level
  • BFAM $105.68
  • MDGL $417.70
  • Resistance Level
  • BFAM $109.34
  • MDGL $463.63
  • Average True Range (ATR)
  • BFAM 2.14
  • MDGL 15.31
  • MACD
  • BFAM -0.63
  • MDGL -3.02
  • Stochastic Oscillator
  • BFAM 0.00
  • MDGL 41.92

About BFAM Bright Horizons Family Solutions Inc.

Bright Horizons Family Solutions Inc provider of early education and child care, family care solutions, and workforce education services that help working families and client employees personally and professionally. It provides services under multi-year contracts with employers that offer early education and child care, back-up care, and educational advisory services as part of their employee benefits package. The company has three business segments; full-service center-based child care, backup care, and educational advisory services. The majority of the revenue is generated by full-service center-based child care, which includes traditional center-based child care and early education services. Other services provided by the company include in-home child and elder care, and Others.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

Share on Social Networks: